POY_1170x120_8-12-19

Medicare Part D and Medicaid

PCMA issues statement on the Administration’s Blueprint on drug pricing

PCMA issues statement on the Administration’s Blueprint on drug pricing

WASHINGTON — Pharmaceutical Care Management Association (PCMA) president and chief executive officer Mark Merritt released the following statement today on the Administration’s Blueprint on drug pricing: “We are encouraged that the Administration’s Blueprint raises several proposals that would increase the use of pharmacy benefit management (PBM) tools to reduce costs in public programs. We support using PBM tools